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| HbA 1c analysis
This study was approved and conducted in accordance with the protocol of the Institutional Medical and Ethics Committee of Peking University Shenzhen Hospital. Written informed consent was obtained from the subject.
A 21-year-old Chinese female was suspected of having a hemoglobin variant after HbA 1c measurement during a routine examination using Variant II Turbo 2.0 [VII-T 2.0] (Bio-Rad, Hercules, CA, USA). An oral glucose tolerance test was performed using an AU5800 clinical chemistry system (Beckman Coulter, Brea, CA, USA 
| Hemoglobin variant investigation
Further test for hemoglobin analysis was performed using C2FP (Hb mode) and Bio-Rad Variant II (β-thalassemia short program).
Hematological parameters were measured using a Sysmex XN9000 hematology analyzer (Sysmex Co., Kobe, Japan).
Genomic DNA was extracted from the patient's blood with a genomic DNA isolation Kit (Tiangen Biotech, Beijing, China), and the in amino acids (Lys>Glu) in codon 16. To the best of our knowledge, this is the first report of Hb I in Chinese people. Previous studies showed Hb I interfered with HbA 1c measurement by HPLC. 6, 7 However, the interference of Hb I on HbA1c has not been determined by CE in previous studies. In the current study, systemati- 
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